Neurobiological Underpinnings to Hypersexual Disorder

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
HypersexualityHypersexual DisorderCompulsive Sexual Behavior
Interventions
OTHER

Brain Imaging

"* Structural MRI (T1 weighted)~* Diffusion Tensor Imaging (DTI)~* resting state functional MRI (rs-fMRI)~* functional MRI (fMRI): Brain activity will be measured in response to sexual images (visually evoked sexual arousal; processing of sexual stimuli), and importantly during a phase when these stimuli are anticipated (neural correlates of wanting and desire; reward anticipation)."

OTHER

Cognitive testing

"We will administer neuropsychological tests assessing objective measures for~* intelligence (Ravens Matrices)~* impulsivity and risk-taking behavior (Balloon Analogue Risk Task)~* inhibitory control (Stop Signal Task)."

OTHER

Psychometric

Administered questionnaires include anxiety and depression symptoms (MADRS, HADS, GAD), drug use (AUDIT, DUDIT), attention deficits (ASRS), impulsivity (BIS-11), reward seeking behavior (BIS/BAS), sexual orientation, (hyper)sexual behavior, desire and compulsivity aspects (HDSI, HBI, SCS, SDI, SIS/SES).

OTHER

Blood test

Blood samples will be taken for routine health assessment, measurement of sex hormonal levels, HPA-axis function test (dexamethasone suppression), and potential DNA extraction and (epi)genetic profiling.

Trial Locations (1)

113 64

Karolinska University Hospital (ANOVA), Stockholm

All Listed Sponsors
collaborator

Karolinska University Hospital, ANOVA, Stockholm (Stefan Arver, Katarina Görts Öberg)

UNKNOWN

lead

Karolinska Institutet

OTHER

NCT03495414 - Neurobiological Underpinnings to Hypersexual Disorder | Biotech Hunter | Biotech Hunter